OSCR
Oscar Health, Inc.
OSCR's fundamentals are strong: revenue grew 55% and its operating margin went from −1.9% to 5.4%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
PLUR
Pluri Inc.
There isn't enough reported data to score PLUR yet.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
PLUR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
PLUR's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
PLUR PE Valuation
PLUR has no meaningful PE right now: it lost money over the past year.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
PLUR Forward outlook
There aren't enough analyst estimates for PLUR to show an outlook.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over PLUR on earnings quality, reporting a profit while its opponent remains loss making.
PLUR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.64 | +$0.49 |
| Q2 2026 | -$2.44 | +$1.12 |
| Q1 2026 | -$2.92 | +$0.69 |
| Q4 2025 | -$3.31 | +$0.37 |
| Q3 2025 | -$3.13 | +$0.98 |
| Q2 2025 | -$3.56 | +$0.43 |
| Q1 2025 | -$3.61 | +$0.60 |
| Q4 2024 | -$3.68 | +$1.04 |
PLUR is still losing money, but far less than before: $2.64 per share over the past year, against $18.08 at its worst in late 2019.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over PLUR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR has the edge over PLUR on profitability, with a higher operating margin.
PLUR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $759K | +140% |
| Q2 2026 | $335K | -16% |
| Q1 2026 | $167K | -61% |
| Q4 2025 | $198K | +7% |
| Q3 2025 | $316K | -3.1% |
| Q2 2025 | $398K | +315% |
| Q1 2025 | $427K | +501% |
| Q4 2024 | $185K | +76% |
PLUR's revenue is growing: $759,000 last quarter, up 140% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -2051% | -42 points |
| Q2 2026 | -1656% | +8 points |
| Q1 2026 | -3914% | -2649 points |
| Q4 2025 | -3286% | -606 points |
| Q3 2025 | -2009% | -415 points |
| Q2 2025 | -1664% | +4622 points |
| Q1 2025 | -1265% | +6530 points |
| Q4 2024 | -2679% | +2285 points |
PLUR's operating margin was −2051% last quarter, down 42 points from the same quarter a year ago.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over PLUR on cash generation, producing positive trailing cash flow while its opponent burns cash.
PLUR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4.5M | +$995K |
| Q2 2026 | -$4.5M | +$1.5M |
| Q1 2026 | -$4.6M | +$324K |
| Q4 2025 | -$5.7M | -$912K |
| Q3 2025 | -$5.5M | -$1.3M |
| Q2 2025 | -$5.9M | -$1.6M |
| Q1 2025 | -$4.9M | -$589K |
| Q4 2024 | -$4.7M | -$970K |
PLUR has burned cash in almost every quarter: −$19M over the past year, against −$21M the year before.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has the edge over PLUR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
PLUR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +21% | +2.1M shares |
| 1 year | +86% | +5.6M shares |
| 3 years | +144% | +7.2M shares |
| 5 years | +229% | +8.5M shares |
| Available history | +512% | +10.2M shares |
PLUR has 12M diluted shares, up 86% from a year ago.
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
PLUR Net Leverage
PLUR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
PLUR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 33.6 | Neutral |
PLUR's weekly RSI is 33 (neutral) and its Stochastic is 34 (neutral).
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
PLUR PE vs Healthcare Sector
PLUR has no meaningful PE right now: it lost money over the past year.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over PLUR on trend strength, trading above more of its moving averages.
PLUR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.06 | 2.8% above |
| 20 week MA | $1.39 | 22% below |
| 50 week MA | $2.42 | 55% below |
| 100 week MA | $3.51 | 69% below |
| 200 week MA | $4.74 | 77% below |
PLUR has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 77% below its 200-week average.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over PLUR on returns for 2026, with the stronger performance.
PLUR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $32.5 | $57.7 | +78% |
| 2021 | $57.7 | $15.5 | -73% |
| 2022 | $15.5 | $8.00 | -48% |
| 2023 | $8.00 | $4.64 | -42% |
| 2024 | $4.64 | $4.55 | -1.9% |
| 2025 | $4.55 | $3.11 | -32% |
| 2026 YTD | $3.11 | $1.09 | -65% |
PLUR has finished five years in a row lower, and it's down 65% so far in 2026.